NCT07882667
Development of a Multidimensional Prediction Model for the Course and Outcome of Early-Onset Juvenile Idiopathic Arthritis (JIA)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Construction of an integrated multiparametric prediction model
Timeframe: 24 months
Secondary (2)
Evaluation of parameters for the prediction of polyarticular extension
Evaluation of parameters for the prediction of iridocyclitis
Arms and interventions
Early-onset JIA patients
Early-onset Juvenile Idiopathic Arthritis (JIA) represents the most common form of arthritis in Western country, affecting the 70-80% of Italian children. It typically occurs before the age of 6, has female predilection, high frequency of positive antinuclear antibodies (ANA),and is characterized by a high risk (20-30% of cases) of chronic iridocyclitis
Iridocyclitis patients not correlated to JIA
Group of control for comparison.
Sites
2 sites in 1 country